Abstract | CONTEXT: OBJECTIVE: The objective of the study was to evaluate whether adding exercise to the VLCD has additional benefits. DESIGN: This was a randomized intervention study. SETTING: The study was conducted at a clinical research center in an academic medical center. SUBJECTS: INTERVENTION: Patients followed a 16-wk VLCD. Thirteen of them simultaneously participated in an exercise program (E) consisting of 1-h, in-hospital training and four 30-min training sessions on a cycloergometer weekly. OUTCOME MEASURES: RESULTS: Baseline characteristics were identical in both groups. Substantial weight loss occurred (-23.7 ± 1.7 kg VLCD-only vs. -27.2 ± 1.9 kg VLCD+E, P = NS within groups). The exercise group lost more fat mass. Insulin-stimulated glucose disposal increased similarly in both study groups [15.0 ± 0.9 to 39.2 ± 4.7 μmol/min(-1) · kg lean body mass (LBM(-1)) VLCD-only vs. 17.0 ± 1.0 to 37.5 ± 3.5 μmol/min(-1) · kg LBM(-1) in VLCD+E], as did phosphorylation of the phosphatidylinositol 3-kinase-protein kinase B/AKT insulin signaling pathway. In contrast, skeletal muscle mtDNA content increased only in the VLCD+E group (1211 ± 185 to 2288 ± 358, arbitrary units, P = 0.016 vs. 1397 ± 240 to 1196 ± 179, P = NS, VLCD-only group). Maximum aerobic capacity also only increased significantly in the VLCD+E group (+6.6 ± 1.7 ml/min(-1) · kg LBM(-1) vs. +0.7 ± 1.5 ml/min(-1) · kg LBM(-1) VLCD-only, P = 0.017). CONCLUSION: Addition of exercise to a 16-wk VLCD induces more fat loss. Exercise augments maximum aerobic capacity and skeletal muscle mtDNA content. These changes are, however, not reflected in a higher insulin-stimulated glucose disposal rate.
|
Authors | Marieke Snel, Amalia Gastaldelli, D Margriet Ouwens, Matthijs K C Hesselink, Gert Schaart, Emma Buzzigoli, Marijke Frölich, Johannes A Romijn, Hanno Pijl, A Edo Meinders, Ingrid M Jazet |
Journal | The Journal of clinical endocrinology and metabolism
(J Clin Endocrinol Metab)
Vol. 97
Issue 7
Pg. 2512-20
(Jul 2012)
ISSN: 1945-7197 [Electronic] United States |
PMID | 22569236
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Hypoglycemic Agents
- Insulin
|
Topics |
- Caloric Restriction
- Calorimetry, Indirect
- Combined Modality Therapy
- Diabetes Mellitus, Type 2
(complications, diet therapy, therapy)
- Exercise
(physiology)
- Exercise Therapy
- Female
- Glucose Clamp Technique
- Glucose Tolerance Test
- Humans
- Hypoglycemic Agents
(therapeutic use)
- Insulin
(therapeutic use)
- Male
- Middle Aged
- Obesity
(complications, diet therapy, therapy)
- Time Factors
|